Use of Breast Cancer Risk Reducing Medications

Principal Investigator

Name
Paul Pinsky

Institution
National Institutes of Health

Position Title
Chief, EDRG

Email
pp4f@nih.gov

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-1749

Initial CDAS Request Approval
Nov 19, 2024

Title
Use of Breast Cancer Risk Reducing Medications

Summary
Assess the use of breast cancer risk reducing medications by breast cancer risk, calendar year, and other factors.

Aims

Compute rates of breast cancer risk reducing medications by breast cancer risk level.

Compute rate of breast cancer risk reducing medications by calendar year

Collaborators

None

Related Publications

• Use of breast cancer risk reducing medications by breast cancer risk level in an older U.S. cohort.
  Pinsky PF, Sauter E, Samimi G
  Cancer Epidemiol. 2025 May 31; Volume 97: Pages 102856 PUBMED